Long-term effects of carvedilol or metoprolol on left ventricular function in ischemic and nonischemic cardiomyopathy

American Journal of Cardiology

Volumn 95, Issue 9, 2005, Pages 1114-1116

  Green, Philip ^b   Anshelevich, Michael ^b   Talreja, Ashok ^b   Burcham, Joyce L ^b   Ravi, Srinivas M ^b   Shirani, Jamshid ^b   Le Jemtel, Thierry H ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CARVEDILOL; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; LOOP DIURETIC AGENT; METOPROLOL; METOPROLOL SUCCINATE; METOPROLOL TARTRATE; WARFARIN;

ADULT; AGED; ARTICLE; BETA ADRENERGIC RECEPTOR BLOCKING; CARDIOMYOPATHY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; ECHOCARDIOGRAPHY; EXPERIENCE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FUNCTION; HUMAN; ISCHEMIC HEART DISEASE; LONG TERM CARE; MAJOR CLINICAL STUDY; PATIENT; PRIORITY JOURNAL; PROSPECTIVE STUDY; SINGLE BLIND PROCEDURE;

EID: 17444364860     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2005.01.030     Document Type: Article

References (11)

1. D.J. Sahn, A. DeMaria, J. Kisslo, A. Weyman Recommendations regarding quantitation in M-mode echocardiography: results of survey of echocardiographic measurements Circulation 58 1978 1072 1083
2. N.B. Schiller, P.M. Shah, M. Crawford Recommendations for quantitation of the left ventricle by two-dimensional echocardiography J Am Soc Echocardiogr 2 1989 58 68
3. R.N. Doughty, G.A. Whalley, G. Gamble, S. MacMahon, N. Sharpe Left ventricular remodeling with carvedilol in patients with congestive heart failure due to ischemic heart disease J Am Coll Cardiol 29 1997 1060 1066
4. F. Waagstein, A. Hjalmarson, K. Swedberg, M.R. Bristow, E.M. Gilbert, F. Camerini, M.B. Fowler, M.A. Silver, M.R. Johnson, F.G. Goss Beneficial effects of metoprolol in idiopathic dilated cardiomyopathy Lancet 342 1993 1441 1446
5. S.A. Hall, C.G. Cigarroa, L. Marcoux, R.C. Risser, P.A. Grayburn, E.J. Eichhorn Time course improvement in left ventricular function, mass and geometry in patients with congestive heart failure treated with beta-adrenergic blockade J Am Coll Cardiol 25 1995 1154 1161
6. C. Maack, T. Elter, G. Nickenig, K. LaRosee, M. Crivaro, A. Stäblein, H. Wuttke, M. Böhm Prospective crossover comparison of carvedilol and metoprolol in patients with chronic heart failure J Am Coll Cardiol 38 2001 939 946
7. T.B. Levine, A.B. Levine, J. Bolenbaugh, P.R. Green Reversal of heart failure remodeling: is it maintained? Clin Cardiol 26 2003 419 423
8. R. DeMaria, A. Di Lenarda, A. Gavazzi Metoprolol-induced functional benefit in dilated cadiomyopathy is sustained over four years and favorably influences outcome Ital Heart J 2 2001 130 138
9. M. Metra, S. Nodari, G. Parrinello, R. Giubbini, C. Manca, L.D. Cas Marked improvement in left ventricular ejection fraction during long term β-blockade in patients with chronic heart failure: clinical correlates and prognostic significance Am Heart J 145 2003 292 299
10. M. Packer, M.R. Bristow, J.N. Cohn, W.S. Colucci, M.B. Fowler, E.M. Gilbert, N.H. Shusterman U.S. Carvedilol Heart Failure Study Group The effect of carvedilol on morbidity and mortality in patients with chronic heart failure N Engl J Med 334 1996 1349 1355
11. MERIT-HF Study Group Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL randomized Interventional Trial in Congestive Heart Failure. (MERIT-HF) Lancet 353 1999 2001 2007